Market Intelligence
Ingredient trends, regulatory signals, competitive moves, and white space analysis across three categories of consumer healthcare. Updated monthly. Prepared by Brendan Walsh, Principal.
Intelligence verticals
Ingredient-level tracking across five high-growth segments. Evidence quality, velocity, and regulatory risk mapped in real time.
Over-the-counter category tracking across four therapeutic segments. Claim landscape, reformulation signals, Rx-to-OTC pipeline, and competitive brand moves.
Ingredient and technology tracking across five oral health segments. Clinical evidence, regulatory positioning, and branded ingredient moves mapped monthly.
FDA and FTC databases, ClinicalTrials.gov, PubMed, and regulatory dockets tracked monthly. Retail velocity from SPINS and Amazon. No aggregator dependency.
Every signal is translated into a concrete implication. Not what happened — what a brand, investor, or advisory client should do with it. Three decades of category experience in every observation.
Intelligence is directional secondary-source analysis unless otherwise noted. Where SPINS or primary data underpins a finding, it is cited. We distinguish signal from noise — and say so when we cannot tell the difference.
This intelligence is prepared for a select audience of brand, investor, and advisory clients. Submit your details — Brendan will follow up directly.
Unlocking full intelligence now. Brendan will be in touch shortly.
Already have access? Contact Brendan directly.